The Trump administration has set preliminary cuts to Medicare reimbursement rates for laboratory services, according to Healthcare Dive. The proposal would reduce annual payments to labs that provide diagnostic testing for Medicare beneficiaries.
The American Clinical Laboratory Association (ACLA) responded with a warning that the steep payment cuts threaten patient access to critical lab testing services. The trade group's concern centers on the cumulative effect of repeated annual reductions, which it argues could erode the financial viability of labs that perform essential tests.
Because the rates are preliminary, they may be revised before finalization. Still, the ACLA's statement signals that industry opposition is likely to intensify as the rule moves through the comment and review process. The proposal highlights the ongoing tension between Medicare cost containment and maintaining the laboratory infrastructure that supports diagnostic care.